Testing effectiveness (Phase 2)Looking for participantsNCT06343311
What this trial is testing
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Who this might be right for
B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-HodgkinsLymphomas Non-Hodgkin's B-Cell+12 more
Estrella Biopharma, Inc. 21